Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
about
Genetic perspective of retinoblastoma: From present to futureUnderstanding pRb: toward the necessary development of targeted treatments for retinoblastomaGenomic differences between retinoma and retinoblastoma.Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counsellingRegulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.Retinoblastoma genetics in India: From research to implementation.Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancerRole of DEAD box 1 in retinoblastoma and neuroblastoma.KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastomaInsights from mouse models into human retinoblastomaMolecular karyotype of sporadic unilateral retinoblastoma tumors.Molecular pathology of retinoblastoma.The genomic landscape of retinoblastoma: a review.Capicua regulates proliferation and survival of RB-deficient cells in Drosophila.RB1 gene inactivation by chromothripsis in human retinoblastomaKIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?Kif14 overexpression accelerates murine retinoblastoma development.Animal models in retinoblastoma research.Gene expression profiling identifies different sub-types of retinoblastoma.Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.Heterogeneity in retinoblastoma: a tale of molecules and models.Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.Functional characterization of E2F3b in human HepG2 liver cancer cell line.Retinoblastoma, the visible CNS tumor: A review.Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.RNA-Sequencing of Primary Retinoblastoma Tumors Provides New Insights and Challenges Into Tumor Development.Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferationRetinoblastomaObservations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14
P2860
Q26744430-B26E1EFC-EB84-452C-B759-A55D314001CCQ27011911-BA2F212A-78CD-42D0-ADB8-A465A6C68B96Q33368684-E5812AA9-1A3E-4A9E-926E-843867380423Q33565434-E36A8E0D-084B-421B-B795-473E12BAF987Q33757922-7D75E72A-DA06-495C-B96B-9C1A9EAF3442Q34159585-BDB8887B-F49F-41A6-864A-FB91955CDA11Q35050767-83E1EA7F-0F5E-4602-9A13-43A664CFD55FQ35120277-19F0A6DE-39E9-45A0-B3E4-0A6DD48D5FCFQ35247713-89A05ACD-A3E8-4368-92C1-DE98176FD766Q35663105-22691A2C-86E0-427B-AFD5-8F4207445C7CQ36765087-E9612E1B-11C1-4FFE-A2C4-B40B46DFED62Q36967323-CE810CDE-622D-4A21-AC62-3827CABBAA5CQ37078840-49D6DAA8-299E-4D92-95D6-C80FA06D6ADAQ37146786-F4075E44-4D85-4AE6-A4BB-5C26FB220753Q37167727-DB84080D-516F-4C6C-BC9F-C31C75F19058Q37292371-1EBEB65D-7B45-4F5B-85BF-790C37DC308BQ37789156-78451EF4-1504-477F-8D3F-3FEBA418BB01Q38179069-250DFAD2-8365-4AFB-8F9D-DAF1C281931EQ38453037-B5E740A6-7058-4F1C-9B36-C6A657DB526FQ38457744-BA8C9CA7-B745-47DC-A71F-2F28AB494C73Q39512476-F69DA6A6-A807-4F97-B3E4-1BFB94B65684Q39704584-474BFF09-4F10-42C6-A3DB-087A51B11758Q42600561-9DED5929-47FA-4C9E-A27F-27B0D5BDE73BQ43077312-025B1109-87B7-4DFD-A6C4-CBDA728EA504Q45087026-F4B07789-9466-4734-8847-D280713F4CE1Q45895694-F57961A8-810B-40F8-BA71-DA2E58216ECBQ47094090-13BCDB14-A432-4255-ADAA-19F4E0D55466Q47405744-338A8227-F005-4A42-BD12-2357ADEB8105Q48288706-73F3DEF7-6F34-44D7-9533-45A528F9DFB2Q50335530-27CF7D8F-3D42-445F-B1E3-05FFACE9088DQ55102301-42CDD9AE-062E-4CA3-ABE6-D5C499B09035Q57497108-B46C1D76-37DE-486B-940C-9B5AE5F84C57Q58347703-377A6986-87E3-4386-8776-C98034F4B209Q58370838-C0D02B99-4CF9-46A8-91E2-D30A7B086952
P2860
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@ast
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@en
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@nl
type
label
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@ast
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@en
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@nl
prefLabel
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@ast
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@en
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@nl
P2093
P2860
P50
P3181
P356
P1476
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
@en
P2093
Ella Bowles
Jane Bayani
Nathalie Wong
P2860
P304
P3181
P356
10.1002/GCC.20383
P407
P577
2007-02-01T00:00:00Z